COSCIENS Biopharma Inc.
CSCI
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 6-K |
11/12/2025 |
Q3 |
2025 |
9/30/2025 |
SEC |
view |
|
| 6-K |
8/14/2025 |
Q2 |
2025 |
6/30/2025 |
SEC |
view |
|
| 6-K |
5/13/2025 |
Q1 |
2025 |
3/31/2025 |
SEC |
view |
|
| 20-F |
4/10/2025 |
Q4 |
2024 |
12/31/2024 |
SEC |
view |
|
| 6-K |
11/12/2024 |
Q3 |
2024 |
9/30/2024 |
SEC |
view |
|
| 6-K |
8/13/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
|
| 20-F/A |
7/17/2024 |
Q4 |
2023 |
12/31/2023 |
SEC |
view |
|
| 6-K |
5/16/2024 |
Q1 |
2024 |
3/31/2024 |
SEC |
view |
|
| 20-F |
3/27/2024 |
Q4 |
2023 |
12/31/2023 |
SEC |
view |
|
| 20-F/A |
2/15/2024 |
Q4 |
2022 |
12/31/2022 |
SEC |
view |
|
| WIREPR |
11/9/2023 |
Q3 |
2023 |
9/30/2023 |
WIRE |
view |
data |
| 6-K |
11/9/2023 |
Q3 |
2023 |
9/30/2023 |
SEC |
view |
|
| WIREPR |
8/9/2023 |
Q2 |
2023 |
6/30/2023 |
WIRE |
view |
data |
| 6-K |
8/9/2023 |
Q2 |
2023 |
6/30/2023 |
SEC |
view |
|
| WIREPR |
5/9/2023 |
Q1 |
2023 |
3/31/2023 |
WIRE |
view |
data |
| 6-K |
5/9/2023 |
Q1 |
2023 |
3/31/2023 |
SEC |
view |
|
| WIREPR |
3/23/2023 |
Q4 |
2022 |
12/31/2022 |
WIRE |
view |
data |
| 20-F |
3/23/2023 |
Q4 |
2022 |
12/31/2022 |
SEC |
view |
|
| WIREPR |
11/3/2022 |
Q3 |
2022 |
9/30/2022 |
WIRE |
view |
data |
| 6-K |
11/3/2022 |
Q3 |
2022 |
9/30/2022 |
SEC |
view |
|
| 6-K/A |
8/4/2022 |
Q2 |
2022 |
6/30/2022 |
SEC |
view |
|
| WIREPR |
8/3/2022 |
Q2 |
2022 |
6/30/2022 |
WIRE |
view |
data |
| WIREPR |
5/11/2022 |
Q1 |
2022 |
3/31/2022 |
WIRE |
view |
data |
| 6-K |
5/11/2022 |
Q1 |
2022 |
3/31/2022 |
SEC |
view |
|
| WIREPR |
3/29/2022 |
Q4 |
2021 |
12/31/2021 |
WIRE |
view |
data |
| 20-F |
3/29/2022 |
Q4 |
2021 |
12/31/2021 |
SEC |
view |
|
| WIREPR |
11/4/2021 |
Q3 |
2021 |
9/30/2021 |
WIRE |
view |
data |
| 6-K |
11/4/2021 |
Q3 |
2021 |
9/30/2021 |
SEC |
view |
|
| 6-K |
8/5/2021 |
Q2 |
2021 |
6/30/2021 |
SEC |
view |
|
| 6-K |
5/5/2021 |
Q1 |
2021 |
3/31/2021 |
SEC |
view |
|
| 40-F/A |
3/29/2021 |
Q4 |
2020 |
12/31/2020 |
SEC |
view |
|
| 40-F |
3/25/2021 |
Q4 |
2020 |
12/31/2020 |
SEC |
view |
|
| 40-F |
3/29/2021 |
Q4 |
2020 |
12/31/2020 |
SEC |
view |
|
| 6-K |
11/5/2020 |
Q3 |
2020 |
9/30/2020 |
SEC |
view |
|
| 6-K |
8/6/2020 |
Q2 |
2020 |
6/30/2020 |
SEC |
view |
|
| 6-K/A |
5/11/2020 |
Q1 |
2020 |
3/31/2020 |
SEC |
view |
|
| WIREPR |
5/6/2020 |
Q1 |
2020 |
3/31/2020 |
WIRE |
view |
data |
| 6-K |
5/6/2020 |
Q1 |
2020 |
3/31/2020 |
SEC |
view |
|
| 20-F |
3/31/2020 |
Q4 |
2019 |
12/31/2019 |
SEC |
view |
|
| WIREPR |
3/30/2020 |
Q4 |
2019 |
12/31/2019 |
WIRE |
view |
data |
| WIREPR |
11/7/2019 |
Q3 |
2019 |
9/30/2019 |
WIRE |
view |
data |
| 6-K |
11/7/2019 |
Q3 |
2019 |
9/30/2019 |
SEC |
view |
|
| WIREPR |
8/13/2019 |
Q2 |
2019 |
6/30/2019 |
WIRE |
view |
data |
| 6-K |
8/13/2019 |
Q2 |
2019 |
6/30/2019 |
SEC |
view |
|
| WIREPR |
5/7/2019 |
Q1 |
2019 |
3/31/2019 |
WIRE |
view |
data |
| 20-F |
4/1/2019 |
Q4 |
2018 |
12/31/2018 |
SEC |
view |
|
| WIREPR |
3/26/2019 |
Q4 |
2018 |
12/31/2018 |
WIRE |
view |
data |
| 20-F |
3/28/2018 |
Q4 |
2017 |
12/31/2017 |
SEC |
view |
|